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New findings
 What is the central question of this study?
Does tuberous sclerosis complex 1–mammalian target of rapamycin (mTOR) signalling
regulate the synthesis of surfactant proteins A and B and, if so, can this contribute to the
postnatal death of Fabp4-Tsc1cKO mice?
 What is the main finding and its importance?
Our study reveals a novel mechanism for the regulation of alveolar surfactant proteins.
Tuberous sclerosis complex 1–mTOR signalling contributes to the regulation of synthesis of
surfactant proteins A and B. Deficiency of tuberous sclerosis complex 1 in alveolar epithelial
cells may contribute to the postnatal death of Fabp4-Tsc1cKO mice.
Tuberous sclerosis complex 1 (TSC1) forms a heterodimmer with tuberous sclerosis complex 2,
to inhibit signalling by the mammalian target of rapamycin (mTOR) complex 1 (mTORC1).
The mTORC1 stimulates cell growth by promoting anabolic cellular processes, such as gene
transcription and protein translation, in response to growth factors and nutrient signals.
Originally designed to test the role of TSC1 in adipocyte function, mice in which the gene for
TSC1 was specifically deleted by the fatty acid binding protein 4 (FABP4)-Cre (Fabp4-Tsc1cKO
mice) died prematurely within 48 h after birth. The Fabp4-Tsc1cKO mouse revealed a much
smaller phenotype relative to the wild-type littermates. Maternal administration of rapamycin,
a classical mTOR inhibitor, significantly increased the survival time of Fabp4-Tsc1cKO mice for
up to 23 days. Both macroscopic and microscopic haemorrhages were observed in the lungs of
Fabp4-Tsc1cKO mice, while other tissues showed no significant changes. Levels of surfactant
proteins A and B demonstrated a significant decrease in the Fabp4-Tsc1cKO mice, which was
rescued by maternal injection of rapamycin. Co-localization of FABP4 or TSC1 with surfactant
protein B was also detected in neonatal pulmonary tissues. Our study suggests that TSC1–
mTORC1 may be critical for the synthesis of surfactant proteins A and B.
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Tuberous sclerosis complex (TSC) is an autosomal
dominant genetic disorder characterized by development
of hamartomas, which can arise in multiple organs,
including brain, kidney, skin and liver (Borkowska et al.
2011). Tuberous sclerosis complex is exclusively associated
with mutations in either the TSC1 or TSC2 tumour
suppressor gene, which encodes the proteins hamartin
and tuberin, respectively. These two proteins form a
complex and function as a negative regulator for the
mammalian target of rapamycin (mTOR) complex 1
(mTORC1) signalling. Interference with TSC1/2 promotes
constitutive activation of mTORC1 (Hay & Sonenberg,
2004). The mTORC1 consists of mTOR, mLST8 (also
termed G-protein h-subunit-like protein, GhL, a yeast
homologue of LST8), raptor (regulatory-associated
protein of mTOR), and PRAS40 (proline-rich Akt
substrate 40 kDa), and is rapamycin sensitive (Dunlop &
Tee, 2009). The mTORC1 regulates translation initiation
by phosphorylation of p70 S6 kinase 1 (S6K1) and
eukaryotic initiation factor 4E binding protein 1, and
functions primarily in the control of a large array of
cellular processes, including cell proliferation, growth,
differentiation and survival (Iadevaia et al. 2012). Recent
studies also reveal that mTORC1 signalling is critical in
the sensing of nutrient availability, and in the regulation
of food intake and energy balance (Cota et al. 2008; Lian
et al. 2008; Cota, 2009; Polak & Hall, 2009; Catania et al.
2011).
Adipose tissue, a fat storage depot and an endocrine
organ, controls energy metabolism, appetite and fertility
in response to nutrients and insulin. Interestingly, the fat
body in Drosophila controls full-body growth in response
to nutrients (Colombani et al. 2003). Downregulation of
TOR signalling, most probably dTORC1, specifically in
the fat body, leads to a significant reduction in overall
body size (Zhang et al. 2000). A full-body knockout
of any component of mTORC1 is embryonically lethal
(Gangloff et al. 2004; Murakami et al. 2004). Mice with
adipose-specific knockout of raptor are lean, resistant
to diet-induced obesity, and demonstrate an increase in
mitochondrial uncoupling in white adipose tissue (Polak
et al. 2008). In addition, these mice show better metabolic
parameters, including improved glucose tolerance and
insulin sensitivity, as well as resistance to diet-induced
hypercholesterolaemia. The higher insulin sensitivity is
attributable to the leanness and to loss of the S6K1 negative
feedback regulation to insulin receptor substrate 1 in
adipose tissue. This phenotype is similar to that of mice
lacking S6K1 (Um et al. 2004), the mTORC1 positive
effector, and opposite to that of mice lacking eukaryotic
initiation factor 4E binding proteins 1 and 2 (Le Bacquer
et al. 2007), the mTORC1 negative effectors. Consistent
with these findings in the adipose-specific raptor knockout
mice, rapamycin treatment causes weight loss in gerbils
(Fraenkel et al. 2008) and prevents weight gain in rats
and humans (Rovira et al. 2008). All these studies suggest
that mTORC1 signalling in adipose tissue is critically
involved in the control of whole-body energy metabolism.
While most of these studies focus on the mTORC1 and
its downstream effectors, little is known about the role of
TSC1/2, the important upstream regulators of mTORC1,
in the development and function of adipose tissues.
This study was originally designed to explore the
effect of TSC1 on adipose tissues. Given that mice
homozygous for Tsc1 or Tsc2 targeted mutations die
by mid-embryogenesis (Kobayashi et al. 1999; Onda
et al. 2002; Wilson et al. 2005), we generated a
colony of mice in which the Tsc1 gene was specifically
deleted by the fatty acid binding protein 4 (FABP4)-
Cre, namely Fabp4-Tsc1cKO mice. Surprisingly, the
Fabp4-Tsc1cKO mice died prematurely within 48 h
after birth. Histological examination revealed significant
haemorrhage, hyperplasia of the alveolar wall and
pulmonary atelectasis. Both mRNA and protein levels
of surfactant proteins (SP) A and B demonstrated a
significant decrease in the Fabp4-Tsc1cKO mice. These
observations suggest that deficiency in the synthesis of
surfactant proteins A and B may impair the postnatal
survival of Fabp4-Tsc1cKO mice.
Methods
Ethical approval
The animals used in this study were handled in accordance
with the Guide for the Care and Use of Laboratory
Animals published by the US National Institutes of Health
(NIH publication no. 85-23, revised 1996), and all the
experimental protocols were approved by the Animal Care
and Use Committee of Peking University.
Animals and animal care
Fabp4-Cre mice that express the Cre recombinase gene
under the control of the Fabp4 gene promoter, as well as
Tsc1lox/lox mice, in which exons 17 and 18 of the Tsc1 gene
are flanked by loxP sites by homologous recombination,
were purchased from the Jackson Laboratory (Bar Harbor,
ME, USA). The Fabp4-Tsc1cKO mice were generated by
breeding Tsc1lox/lox mice with Fabp4-Cre mice. Control
experiments were performed using littermate Tsc1lox/lox
animals. Deletion of the Tsc1 gene was validated by the
absence of its mRNA and the elevation of mTOR activity
measured by the increased phosphorylation of S6 and
mTOR in brown fat tissues. Mice were housed on a
12 h–12 h light–dark cycle. Normal chow and water were
available ad libitum.
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Rapamycin treatment
Rapamycin (Santa Cruz Biotechnology, Inc., Santa Cruz,
CA, USA) was initially dissolved in 100% DMSO, stored
at –20◦C, and further diluted in DMSO immediately
before use. Pregnant mice were randomly divided into
two groups. At the near-term pregnancy, mice were
injected intramuscularly with rapamycin (1 mg (kg body
weight)−1 day−1) or vehicle for 3 days before the birth of
pups. Administration of rapamycin to mother mice at the
same dose continued for 2 days after labour. Neonatal mice
were closely observed for life signs to assess the survival of
the offspring.
Cell culture and plasmid transfection
A549 cells (American Type Culture Collection) were
cultured in growth medium (high-glucose Dulbecco’s
modified Eagle’s medium; Invitrogen, Grand Island,
NY, USA) supplemented with 10% fetal bovine
serum, 100 units ml−1 penicillin and 100 units ml−1
streptomycin. A549 cells were seeded 24 h prior
to transfection. The plasmids of mTOR–wild-type
(mTOR-WT), mTOR kinase death mutant (mTOR-
KD) and green fluorescent protein (GFP)-pcDNA3.0
were transfected using TurboTectTM in vitro Transfection
Reagent (Fermantas, Vilnius, Lithuania) according to the
manufacturer’s protocol.
Extraction of RNA and quantitative real-time PCR
analysis
Total RNA was isolated using the TRIzol reagent
(Invitrogen, Carlsbad, CA, USA). Reverse transcription
and quantitative real-time PCR were performed as
previously described (Li et al. 2008; Xu et al. 2009). The
PCRs were performed in duplicate, and each experiment
was repeated between three and five times. Primers used
in this study are shown in Table 1.
Western blot analysis
Tissues extracts were immunoblotted with SP A
(Santa Cruz Biotechnology, Inc., Santa Cruz, CA,
USA), SP B (CST, Beverly, MA, USA), FABP4
(Abcam, Cambridge, MA, USA), glyceraldehyde 3-
phosphate dehydrogenase (GAPDH; CST) and β-actin
(CST) as previously described (Li et al. 2008; Xu
et al. 2009). The specific reaction was detected using an
IRDye-conjugated second antibody for 1 h incubation and
visualized using the Odyssey infrared imaging system (LI-
COR Biosciences, Lincoln, NE, USA). The signals were
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Immunostaining
The lungs were quickly removed and prepared for
immunostaining as previously described (Xu et al. 2009).
Slides were individually incubated with TSC1 (1:100
dilution; CST) or phosphorylated mTOR (p-mTOR;
Ser 2448) antibody (1:100 dilution; CST) in a humid
chamber at 4◦C overnight. Secondary antibody staining
was performed with a biotin-labelled horse anti-rabbit
antibody (1:200 dilution) for 1 h at room temperature,
followed by incubation with a streptavidin–biotin
horseradish peroxidase complex (Vector Laboratories,
Burlingame, CA, USA). Immunoreactivity was detected
using diaminobenzidine substrate (peroxide substrate kit,
SK-4100; Vector Laboratories) for 2–5 min. Slides were
then counterstained with Mayer’s Haematoxylin before
dehydration and mounting. The expressions of TSC1
and p-mTOR were analysed by comparing the staining
intensities between different samples with and without the
addition of a primary antibody in the same conditions.
Double immunostaining
Paraffin-embedded sections were incubated overnight
with a mixture of rabbit polyclonal antibodies to FABP4
(1:100 dilution) or TSC1 (1:100 dilution) and mouse
monoclonal antibody to SP B (1:50 dilution), then
incubated with the mixture of the following secondary
antibodies: goat anti-rabbit fluorescein isothiocyanate-
conjugated IgG (1:100 dilution) and goat anti-mouse
Texas Red-conjugated IgG (1:100 dilution). Controls
included substitution of primary antibodies with mouse
IgG or rabbit IgG. The FABP4 or TSC1 and SP B
positive cells were evaluated using Image Plus software
(fCoder Group, Inc., Alexandria, VA, USA) to quantify
the fluorescence intensity inside the cells. Cells with
fluorescence intensity ≥150% of background were
considered positive. A total of 15 tissue sections from five
mice were evaluated.
Statistical analysis
Data are expressed as means ± SEM. Data analysis used
GraphPad Prism software (GraphPad Software Inc., La
Jolla, CA, USA). One-way ANOVA, Student–Newman–
Keuls test (comparisons between multiple groups) or
Student’s unpaired t test (between two groups) was used
as appropriate. A value of P < 0.05 denotes statistical
significance.
Results
Postnatal death of Fabp4-Tsc1cKO mice and the
rescuing effect of rapamycin
As shown in Fig. 1, Fabp4-Tsc1cKO mice were significantly
smaller relative to their littermates (Fig. 1A and B), while
Figure 1. Phenotype of Fabp4-Tsc1cKO mice
A, Fabp4-Tsc1cKO mice (KO) are smaller relative to their wild-type littermates (WT). Body weight (B) and
length from nose to tail base (C) were measured and are presented as means + SEM. D, life signs were
closely observed to assess survival and are presented as survival days and rates. E shows the rescuing
effect of rapamycin on the survival of Fabp4-Tsc1cKO mice. ∗P < 0.01(n = 6–20).
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the body length showed no difference (Fig. 1C). Postnatal
death occurred in all Fabp4-Tsc1cKO mice. All mice died
prematurely within 48 h after birth, with over 60% of
death occurring during the first 24 h (Fig. 1D). In order
to determine the specific effect of Tsc1 gene deletion in
tissues expressing FABP4, we examined the rescuing effect
of rapamycin, a specific inhibitor of mTOR signalling, on
the survival of Fabp4-Tsc1cKO mice. As shown in Fig. 1E,
administration of rapamycin at a dose of 1 mg kg−1 day−1
to the near-term pregnant mice significantly increased
the survival rate of Fabp4-Tsc1cKO mice. The
maximal survival time was extended up to 23 days
(Fig. 1E).
Expression of FABP4 in neonatal mice and adult mice
A series of studies were next performed to determine
the potential cause of postnatal death in Fabp4-Tsc1cKO
mice. We first examined the tissue expression of FABP4.
Differential expression of FABP4 was observed in neonatal
and adult mice. In adult mice, FABP4 expression was
limited to being present only in brown and white adipose
tissues (Fig. 2A). In contrast, neonatal mice demonstrated
a distribution of FABP4 in a wide range of tissues (Fig. 2B).
In addition to brown and white adipose tissues, FABP4 was
detected in lung, heart, skin and kidney, and in liver and
brain at a lower level in neonatal mice.
Pulmonary lesions in Fabp4-Tsc1cKO mice
We next examined the histological changes in FABP4-
expressing tissues derived from the neonatal FABP4-
Tsc1cKO mice. No significant histological alteration
was observed in tissues such as heart (Fig. 3A), liver
(Fig. 3B), skin (Fig. 3C), kidney (Fig. 3D) and pancreas
(Fig. 3E). However, macroscopic haemorrhage was
observed in the lungs (Fig. 4A). Haematoxylin and Eosin
staining confirmed significant pathological lesions in
pulmonary tissues, including haemorrhage, hyperplasia
of the alveolar walls and pulmonary atelectasis (Fig. 4B).
Given that hypoxia-inducible factor-1α (HIF-1α) and
vascular endothelial growth factor (VEGF) have been
reported to be associated with haemorrhage, we next
examined the expression of HIF-1α and VEGF in the lungs
of Fabp4-Tsc1cKO mice. As shown in Fig. 4C and D, mRNA
levels of HIF-1α and VEGF were markedly increased in the
pulmonary tissues in Fabp4-Tsc1cKO mice relative to the
wild-type animals.
Expression of TSC1 and p-mTOR in the lung
of Fabp4-Tsc1cKO mice
In order to validate the deletion of Tsc1 in the pulmonary
tissue of Fabp4-Tsc1cKO mice, we next examined the
expression of TSC1 and p-mTOR by immunostaining.
As shown in Fig. 5A, TSC1 immnoreactivity was
detected in the pulmonary epithelial cells, whereas
no positive signal was demonstrated in the Fabp4-
Tsc1cKO mice. Consistent with the change in the
TSC1 level, Fabp4-Tsc1cKO mice demonstrated a much
stronger signal for p-mTOR staining in the alveolar
epithelial cells (Fig. 5B). These results suggest that TSC1
inactivation enhances mTOR activity in the pulmonary
epithelia.
Decrease of alveolar surfactant proteins A and B in
Fabp4-Tsc1cKO mice
Given that surfactant proteins secreted by type II alveolar
epithelial cells play a central role in pulmonary ventilation,
levels of alveolar SPs were then examined. As shown
in Fig. 6A, mRNA levels of pulmonary SP A and SP B
were markedly decreased in the pulmonary tissues derived
from the neonatal Fabp4-Tsc1cKO mice, whereas SP C
demonstrated no significant change. This change was
associated with a significant reduction in the protein levels
of both SP A and SP B (Fig. 6B).
Administration of rapamycin at a dose of
1 mg kg−1 day−1 into the near-term pregnant mice
prevented the reduction of SP A and SP B mRNA
(Fig. 6C).
Figure 2. Expression of fatty acid binding protein 4 (FABP4) in
neonatal and adult mice
Tissues were harvested from neonatal and adult mice, and
subjected to SDS-PAGE and Western blot analysis as described in
the Methods. Representative results of four individual
experiments are shown for the FABP4 expression in a group of
tissues derived from adult (A) and neonatal mice (B).
Abbreviation: GAPDH, glyceraldehyde 3-phosphate
dehydrogenase.
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To further test the effect of mTOR signalling in the
regulation of SP A and SP B transcription, A549 cells, a
human alveolar basal epithelial cell line, were transfected
with mTOR-WT or mTOR-KD plasmids to increase and
decrease the mTOR signalling in these cells, respectively. As
a control, GFP-pcDNA3.0 was used. As shown in Fig. 6D,
mRNA levels of SP A and SP B were markedly decreased
after activation of mTOR by mTOR-WT plasmid, whereas
inhibition of mTOR by mTOR-KD plasmid increased the
mRNA levels of SP A and SP B.
Co-localization of FABP4 or TSC1 with surfactant
protein B in alveolar epithelium
Double immunofluorescent staining was performed to co-
localize the expression of FABP4 or TSC1 with SP B in
the neonatal lung tissues. As shown in Fig. 7A, antibody
recognizing FABP4 showed a positive reaction in the
alveolar epithelial cells that were also reactive for SP B.
Likewise, co-localization of TSC1 immunoreactivity with
SP B was observed in the alveolar epithelial cells (Fig. 7B).
Control antibodies produced no positive signal.
Discussion
Our present study demonstrates that conditional deletion
of Tsc1 driven by the Fabp4 promoter causes a deficiency
in the synthesis of surfactant proteins A and B, which
may at least partly contribute to the postnatal death
of Fabp4-Tsc1cKO mice. This conclusion is supported
by the following observations: (i) Fabp4-Tsc1cKO mice
die within 48 h after birth; (ii) inhibition of mTORC1
signalling by rapamycin rescues the mice from postnatal
death; (iii) a much wider expression of FABP4 is found
in neonatal tissues, including the lungs; (iv) levels of
alveolar surfactant proteins A and B are significantly
decreased in Fabp4-Tsc1cKO mice; (v) there exists a
negative relationship between mTOR signalling and SP A
and SP B transcription in the cultured alveolar epithelial
cells; and (vi) FABP4 or TSC1 co-localizes with surfactant
protein B in alveolar epithelial cells of the neonatal lungs.
Fatty acid binding protein 4, also known as adipocyte-
FABP, was first detected in mature adipocytes and adipose
tissue (Reese-Wagoner et al. 1999). This protein was
originally termed adipocyte P2 (aP2) because of its high
Figure 3. Morphology of tissues of the Fabp4-Tsc1cKO mice
All tissues were harvested from neonatal mice and processed for Haematoxylin and Eosin staining.
Histological evaluation revealed no significant pathological change in heart (A), liver (B), skin (C), kidney
(D) and pancreas (E) in the Fabp4-Tsc1cKO mice (KO) compared with their wild-type littermates (WT).
C© 2012 The Authors. Experimental Physiology C© 2012 The Physiological Society
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sequence similarity (67%) to peripheral myelin protein 2
(M-FABP/FABP8). Originally identified as an adipocyte-
specific protein (Spiegelman & Green, 1980), the promoter
of Fabp4 has been widely used to target adipose tissue-
specific gene expression in mice (Ross et al. 1990; Barlow
et al. 1997; He et al. 2003). Two different lines of Fabp4-
Cre mice have been used in most published studies. One
was developed in Dr Barbara Kahn’s laboratory at Harvard
University (Abel et al. 2001) and the other in Dr Ronald
Evans’s laboratory at the Salk Institute (He et al. 2003).
In both lines, Cre activity is expressed in white and brown
adipose tissues in adult mice. Our study used the latter line,
which is commercially available from Jackson Laboratory
(stock no. 005069).
Most Fabp4-Cre-mediated gene knockout mice can
survive, but there also are some exceptions. Ablation of the
Vhl gene in adipose driven by the Fabp4 gene promoter
exhibits embryonic lethality at embyonic day 14.5–18.5,
which results from haemorrhages in the brain and liver
induced by the upregulation of HIF-1α/VEGF activity
(Zhang et al. 2012). In addition, Mudhasani et al. (2011)
showed that mice with Fabp4-Cre-driven deletion of dicer
gene typically died within 3 weeks after birth, shortly
before weaning. These results suggest an expression of
FABP4 outside the adipose tissues. Indeed, recent studies
have demonstrated a wider expression of FABP4 in an
array of cells and tissues, including macrophages upon
their differentiation from monocytes, human bronchial
epithelial cells, arterial endothelial cells, trophoblasts,
liver, skeletal muscle fibres, lipoblastoma and liposarcoma,
and human urothelial carcinomas (Shum et al. 2006;
Biron-Shental et al. 2007; Lee et al. 2007; Ferrell et al.
2008; Boiteux et al. 2009; Elmasri et al. 2009; Scifres
et al. 2011). Consistent with these findings, our study
suggests that FABP4 is present in a wide range of tissues
during development and becomes adipocyte specific in
adulthood. Taken together, all these findings may challenge
the previous concept on the use of Fabp4 promoter
to target adipose tissue-specific gene expression during
development.
Figure 4. Pulmonary lesions of the Fabp4-Tsc1cKO mice
The lungs were taken from neonatal Fabp4-Tsc1cKO mice (KO) and wild-type littermates (WT). A,
photographs were taken under the stereoscope. Macroscopic haemorrhage was observed in the lungs of
the Fabp4-Tsc1cKO mouse. B, Haematoxylin and Eosin staining of lung tissue sections shows pulmonary
lesions, including haemorrhage, hyperplasia of the alveolar walls and pulmonary atelectasis. The mRNA
levels of hypoxia-inducible factor-1α (HIF-1α; C) and vascular endothelial growth factor (VEGF; D) were
markedly increased in the pulmonary tissues in Fabp4-Tsc1cKO mice relative to the wild-type animals.
∗P < 0.05, ∗∗P < 0.01 (n = 6).
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In our animal model of Fabp4-Tsc1cKO mice, specific
deletion of the Tsc1 gene driven by Fabp4 promoter
causes postnatal death. Conditional deletion of Tsc1 driven
by the Fabp4 promoter is confirmed by the absence of
TSC1 mRNA and activation of mTOR as measured by
increased phosphorylation of S6 and mTOR in the brown
adipose tissues (data not shown). Previous studies have
demonstrated that either TSC1 or TSC2 is critical for
Figure 5. Expression of tuberous sclerosis complex 1 (TSC1) and phosphorylated mammalian target of
rapamycin (p-mTOR)in the lungs of Fabp4-Tsc1cKO mice
The immunoreactivity for TSC1 (A) and p-mTOR (B) is shown in the lung tissues. A specific signal was
observed in the alveolar epithelial cells. Relative to the wild-type mice, TSC1 immunoreactivity was
significantly reduced, whereas the p-mTOR signal intensity was higher in the pulmonary tissues of
Fabp4-Tsc1cKO mice.
Figure 6. Decrease in the surfactant proteins A and B in the Fabp4-Tsc1cKO mice and the rescuing effect
of rapamycin
The mRNA and protein were extracted from the pulmonary tissues harvested from the Fabp4-Tsc1cKO
mice (KO) and wild-type littermates (WT; A–C) or A549 cells (D). Real-time RT-PCR and Western blotting
were performed to evaluate the expression of surfactant proteins A, B and C. Results are expressed as
means + SEM. A, results of surfactant proteins A, B and C mRNA expression in WT and KO. ∗∗P < 0.01
(n = 6). B, representative results of Western blot. β-Actin was used as the loading control. ∗∗P < 0.01
(n = 6). C, the rescuing effect of maternal rapamycin administration on the transcription of surfactant
proteins A and B mRNA in WT and KO mice. ∗P < 0.05 (n = 6) compared with WT + DMSO group.
#P < 0.05 (n = 6) compared with KO + DMSO group. D, effects of overexpression of mTOR-WT and
mTOR-KD plasmids on the mRNA expression of surfactant proteins A and B. Cells trasfected with GFP-
pCDNA3.0 were used as the control. ∗P < 0.05, ∗∗P < 0.01 (n = 3).
C© 2012 The Authors. Experimental Physiology C© 2012 The Physiological Society
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survival (Tomasoni & Mondino, 2011). Mice homozygous
for Tsc1 targeted mutations die by mid-embryogenesis,
while a significant number of heterozygous (Tsc1+/−)
mice on the C57BL/6 background die in the postnatal
period, normally at 1–2 days, from unknown causes
(Wilson et al. 2005). In humans, mutation of either the
Tsc1 or the Tsc2 gene causes tuberous sclerosis complex,
a multisystem genetic disease, which is commonly
characterized by neurological symptoms, such as seizures,
autism, mental retardation and learning disabilities. While
neuronal dysfunction is common in tuberous sclerosis
complex, it is unlikely that the dysfunction of the
central nervous system is the leading cause of embryonic
or neonatal death. In a mouse tuberous sclerosis
epilepsy model, conditional deletion of Tsc1 in astrocytes
induces epilepsy commonly observed in tuberous sclerosis
complex patients, and these mice survive until adulthood
(Uhlmann et al. 2002). The present study reveals a
novel mechanism for the postnatal death of Fabp4-
Tsc1cKO mice. Significant pathological changes, which
include haemorrhage, hyperplasia of the alveolar walls
and pulmonary atelectasis, are observed in these mice.
The pulmonary haemorrhage may be due to the defect in
the blood vessel structure induced by HIF-1α activation.
A high level of HIF-1α has been reported to stimulate
the expression of VEGF, which subsequently increases
capillary permeability (Weis & Cheresh, 2005; Zhang et al.
2012).
Figure 7. Co-localization of FABP4 or TSC1 with surfactant protein B
Images depict FABP4 or TSC1 (green) and surfactant protein B (red) in alveolar epithelial cells. Merged
images illustrate co-localization of surfactant protein B and FABP4 (orange; A) or TSC1 (B). Controls
included substitution of primary antibodies with mouse IgG and rabbit IgG. Cells expressing FABP4 or
TSC1 and surfactant protein B are indicated by white arrows. Top panels, low magnification (LP); bottom
panels, high magnification (HP).
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Exp Physiol 98.3 (2013) pp 830–841 Tuberous sclerosis complex 1 and pulmonary surfactant proteins 839
Neonatal respiratory distress syndrome is caused
by inadequate amounts of pulmonary surfactant due
to delayed lung development (Avery & Mead, 1959).
Surfactant, a lipoprotein comprised of phospholipids
(∼80%), cholesterol (∼10%) and proteins (∼10%),
functions to reduce surface tension and to prevent alveolar
collapse at end expiration (Weaver & Whitsett, 1991).
Surfactant deficiency or dysfunction is associated with
the occurrence and development of many pulmonary
diseases, such as neonatal respiratory distress syndrome,
acute respiratory distress syndrome, asthma and chronic
obstructive pulmonary disease (Wright, 2003). Four
types of surfactant proteins (A, B, C and D) have
been reported (Weaver & Whitsett, 1991). Surfactant
protein A is the most abundant, while SP B is crucial
for the adsorption of the surfactant film at the
alveolar air–liquid interface (Whitsett & Weaver, 2002).
Surfactant protein B has been demonstrated to be
critical for normal gas exchange in the perinatal period
and is therefore indispensable for neonatal survival.
Our study suggests that the neonatal death of Fabp4-
Tsc1cKO mice may result from a deficiency in the synthesis
of SP A and SP B in Fabp4-Tsc1cKO mice. First, both the
mRNA and the protein levels of SP B are markedly reduced
in the Fabp4-Tsc1cKO mice. Maternal administration of
rapamycin prevents the reduction of SP B induced by the
activation of mTOR signalling and significantly extends
the survival time of the Fabp4-Tsc1cKO mice. Second,
an alteration in mTOR signalling directly modulates the
transcription of SP B in cultured alveolar epithelial cells.
Third, FABP4 or TSC1 co-localizes with SP B in the
alveolar epithelial cells. It is well known that type II
cells synthesize SP A and SP B in the lung. Our studies
indicate that TSC1–mTOR signalling may simultaneously
modulate the synthesis of both SP A and SP B in these
cells. Taken together, all these observations suggest that
TSC1 may be involved in the regulation of SP A and
SP B, and specific deletion of Tsc1 driven by the Fabp4
promoter may impair the synthesis of SP A and SP B
in the alveolar epithelial cells. This finding is consistent
with the previous reports by Ikeda et al. (2011), in
which aberrant activation of the Akt–mTOR signalling
pathway in lung epithelium causes infant respiratory
distress syndrome, and by Miakotina et al. (2002), in which
the rapamycin-sensitive phosphoinositide 3-kinase–S6K1
signalling pathway is demonstrated to mediate insulin-
induced inhibition of SP A mRNA levels in lung epithelial
cells.
In conclusion, our studies suggest a novel mechanism
for the regulation of alveolar surfactant proteins. Tuberous
sclerosis complex 1 contributes to the regulation of
synthesis of surfactant proteins A and B. Deficiency of
TSC1 in alveolar epithelial cells may partly contribute to
the postnatal death of Fabp4-Tsc1cKO mice.
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